Justin W. Yorke, Director at Processa Pharmaceuticals, Inc. (PCSA), sold 1,854 shares at $3.30 ($6K) on 2022-01-27, disclosed to the SEC on 2022-01-31.
Open-market sale of $6k PCSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCSA | SELL | 2021-12-07 | $46K | — | Filing → |
| PCSA | SELL | 2021-04-15 | $220K | — | Filing → |